Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-0313
version: 5
kind: sources_changed
reason: Source set updated
timestamp: 2026-10-15T06:55:46.752958Z
status: published
lens: p_space
sector: health
headline: Embedded transparency in artificial intelligence: a prerequisite for equity and representation in AI-enabled clinical trials
dek: Artificial intelligence is being embedded in clinical trial infrastructure, shaping who is identified, stratified, and analysed. Opaque models risk amplifying existing disparities in the evidence base. We argue that embedded transparency, the structural integration of ex ante interpretability, demographic auditability, documented uncertainty handling, and stakeholder-relative explanation, is a necessary, though not sufficient, condition for equitable AI-enabled trials, and propose governance recommendations acti…
gain_title: (none)
problem_title: Opaque AI models embedded in clinical trial infrastructure risk amplifying existing disparities in the evidence base by shaping who is identified and analyzed.
trace_subject: (none)
gain_reading: (none)
gain_evidence: (none)
problem_reading: Opaque AI models embedded in clinical trial infrastructure risk amplifying existing disparities in the evidence base by shaping who is identified and analyzed.
problem_evidence: Opaque models risk amplifying existing disparities in the evidence base. | Artificial intelligence is being embedded in clinical trial infrastructure
quick_read: As of the July 2026 publication date, the authors describe AI being embedded in clinical trial infrastructure and argue that opaque models risk amplifying disparities. They propose embedded transparency as a structural prerequisite for equitable trials and outline governance recommendations.

This matters because trial infrastructure determines whose data informs evidence and treatment guidance. The paper does not report measured improvements in representation from an intervention, leaving uncertainty about effectiveness, implementation costs, and how transparency interacts with other drivers of inequity. 
limitation: 
tag: Model-prefilled problem
key_points: AI is being embedded in clinical trial infrastructure and influences participant identification and stratification. | Authors define embedded transparency as structural integration of interpretability, demographic auditability, uncertainty handling, and stakeholder-relative explanation. | Paper proposes governance recommendations intended to be actionable across regulatory regimes.
rundown: The authors conceptualize embedded transparency as ex ante interpretability, demographic auditability, documented uncertainty handling, and stakeholder-relative explanation built into trial systems.

They frame opaque models as a risk factor for amplifying disparities in the evidence base and position transparency as a governance requirement across regulatory regimes.
sources:
- peer_reviewed | American Journal of Advanced Technology and Engineering Solutions | https://doi.org/10.63125/zyvt7f56 | 2020-01-01
- peer_reviewed | International Journal of Innovative Technologies in Social Science | https://doi.org/10.31435/ijitss.3(47).2025.3589 | 2025-09-01
- peer_reviewed | Medicine International | https://doi.org/10.3892/mi.2025.289 | 2025-12-09
- peer_reviewed | npj Digital Medicine | https://doi.org/10.1038/s41746-026-02987-7 | 2026-07-11
- peer_reviewed | Signal Transduction and Targeted Therapy | https://doi.org/10.1038/s41392-026-02631-6 | 2026-06-02
prev: 7b0d57bf70ff5966d24645c34675efb8a1edfdae91ccc535ac3f292f41e45203

sha256

cda3acbfc0db89762adadf5da0b44fc4164cd6465a587e28d47093c550cc6919

previous

7b0d57bf70ff5966d24645c34675efb8a1edfdae91ccc535ac3f292f41e45203